Electromed (ELMD) EBT Margin Growth (1y) (2011 - 2026)

Electromed (ELMD) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -419.00
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 110.00
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 458.00
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 507.00
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -287.00
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 772.00
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 233.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -464.00
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Electromed 313.26 Mn 296.27 Mn 14.64 Mn 626.00

Historic Data

Download Data
DateValue
Mar 31, 2026 626.00
Dec 31, 2025 316.00
Sep 30, 2025 206.00
Jun 30, 2025 142.00
Mar 31, 2025 41.00
Dec 31, 2024 -66.00
Sep 30, 2024 1,276.00
Jun 30, 2024 556.00
Mar 31, 2024 401.00
Dec 31, 2023 631.00
Sep 30, 2023 133.00
Jun 30, 2023 685.00
Mar 31, 2023 156.00
Dec 31, 2022 36.00
Sep 30, 2022 -502.00
Jun 30, 2022 -244.00
Mar 31, 2022 569.00
Dec 31, 2021 -622.00
Sep 30, 2021 -293.00
Jun 30, 2021 -1,202.00